Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00012181
Status:
COMPLETED
Last Update Posted:
2013-07-02
First Post:
2001-03-03
Brief Title:
Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unspecified Childhood Solid Tumor Protocol Specific |
| Recurrent Childhood Brain Stem Glioma |
| Recurrent Childhood Cerebellar Astrocytoma |
| Recurrent Childhood Cerebral Astrocytoma |
| Recurrent Childhood Ependymoma |
| Recurrent Childhood Large Cell Lymphoma |
| Recurrent Childhood Liver Cancer |
| Recurrent Childhood Lymphoblastic Lymphoma |
| Recurrent Childhood Malignant Germ Cell Tumor |
| Recurrent Childhood Medulloblastoma |
| Recurrent Childhood Rhabdomyosarcoma |
| Recurrent Childhood Small Noncleaved Cell Lymphoma |
| Recurrent Childhood Soft Tissue Sarcoma |
| Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor |
| Recurrent Childhood Visual Pathway and Hypothalamic Glioma |
| Recurrent Childhood Visual Pathway Glioma |
| Recurrent Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor |
| Recurrent Neuroblastoma |
| Recurrent Osteosarcoma |
| Recurrent Retinoblastoma |
| Recurrent Wilms Tumor and Other Childhood Kidney Tumors |
| RecurrentRefractory Childhood Hodgkin Lymphoma |
Keywords: